TETenax Therapeutics, Inc. TENX · NASDAQ
$1.52 +11.76% (+$0.16)
- Market cap
- $40.3M
- Enterprise value
- -$77.7M
- P/E
- -
- Forward P/E
- -
- PEG
- -
- P/S
- -
- P/FCF
- -
- EV/EBITDA
- -
- ROIC
- -60.4%
- Bruto marža
- -
- Neto marža
- -
- Dividend yield
- -
- Payout ratio
- -
- Neto dolg/EBITDA
- -
- Beta
- 0.92
- Free float
- 99.8%
O podjetju
Tenax Therapeutics, Inc. (TENX) is a pharmaceutical company specializing in the development and commercialization of drugs for cardiovascular diseases and other serious health conditions. With high standards of scientific research and innovative treatment methods, Tenax Therapeutics is a key player in the pharmaceutical industry. Their products have the potential to improve treatment and the quality of life for patients with cardiovascular issues. The company is known for its commitment to scientific excellence and innovations in the field of pharmacy. Tenax Therapeutics, Inc. (TENX) shares could be suitable for investors looking to invest in a sector with high potential for scientific advancement and improved healthcare.
Sector
Healthcare
Industry
Biotechnology
CEO
Christopher T. Giordano
Employees
15
Headquarters
Chapel Hill
Vrednotenje
Je današnja cena primerna?
Rast in ocene
Ali podjetje raste in kaj sledi?
Donosnost in kakovost
Koliko prihodkov ostane in kako dobro podjetje uporablja kapital?
Finančno zdravje
Ali zmore svoj dolg?
Kapital in dividende
Kaj podjetje počne z zasluženim denarjem?
Analitiki
Kaj menijo strokovnjaki in ali se to spreminja?
Lastniki in insajderji
Kdo ima delnice in kaj počne vodstvo?
Segmenti
Kateri del podjetja raste?
Primerjava s konkurenco
Kako se primerja s podobnimi podjetji?
Cena in tveganje
Kako se delnica obnaša?
Izkazi
Vse številke